POZELIMAB

UNII:	0JJ21K6L2I
Formula:
Preferred Substance Name:	POZELIMAB

2096328-94-6
IMMUNOGLOBULIN G4 (228-PROLINE), ANTI-(HUMAN COMPLEMENT C5) (HUMAN MONOCLONAL REGN3918 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN3918 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS C5 (COMPLEMENT C5)), HOMO SAPIENS MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN HOMO SAPIENS (1-447) (VH (HOMO SAPIENS IGHV4-59*02 (94.8%)-(IGHD)-IGHJ4*01 (100%)) (8.7.14) (1-120)-HOMO SAPIENS IGHG4*01 (CH1 (121-218), HINGE S10>P (228) (219-230), CH2 (231-340), CH3 (341-445), CHS (446-447)) (121-447)), (134-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-6*01 (96.8%)-IGKJ1*01 (100%)) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214'))DIMER (226-226'':229-229'')-BISDISULFIDE
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS COMPLEMENT C5)HUMAN MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-447) (HOMO SAPIENS VH (IGHV4-59*02 (95%) (IGHD)-IGHJ4*01) (8.7.14) (1-120)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(228))) (121-447)) (134-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV1-6*01 (97%) IGKJ1*01)(6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (226-226'':229-229'')-BISDISULFIDE
POZELIMAB [INN]
POZELIMAB [USAN]
POZELIMAB [WHO-DD]
POZELIMAB-BBFG
REGN3918
REGN-3918
VEOPOZ

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

POZELIMAB

Synonyms and Mappings

Resources